Cleerly, a pioneer in advanced cardiovascular imaging, is thrilled to announce that the American Medical Association (AMA) has approved a CPT Category I code for its AI-QCT advanced plaque analyses.
Cleerly to Present Late-Breaking Findings and Participate in Key ACC.25 Sessions Cleerly, the leader in cardiovascular AI imaging, announces its participation in the American College of Cardiology ...
New insights reveal standard cholesterol tests are insufficient for heart health. Dr. Vassily Eliopoulos highlights that many ...
Perfect cholesterol levels do not guarantee a healthy heart. Dr Vassily Eliopoulos warns that standard tests miss hidden ...
Cardiovascular imaging company Cleerly announced it raised $106 million in a Series C funding round. The round was led by Insight Partners and Battery Ventures, with participation from preexisting ...
Cybersecurity is important to every industry, but none more so than in healthcare, which is some of the most personal information you can get on a person. Yet, nearly 50 million Americans had their ...
NEW YORK--(BUSINESS WIRE)--Cleerly, the company creating a new standard of care for heart disease, announced today it has appointed Krissy Wright as Chief Financial Officer (CFO) and Sandra Statz as ...
After proving that its noninvasive artificial intelligence software is comparable to the current gold standard of coronary angiography in spotting signs of heart disease, Cleerly has cleared a path to ...
Heart disease has long been the number one cause of death in the U.S. and some of the stats are startling: an American will have a heart attack approximately every 40 seconds for a total of 805,000 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback